Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma.

Terpos, Evangelos

Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma. [electronic resource] - International journal of cancer Sep 2003 - 455-7 p. digital

Publication Type: Comparative Study; Journal Article

0020-7136

10.1002/ijc.11247 doi


Acid Phosphatase--blood
Adult
Aged
Aged, 80 and over
Alkaline Phosphatase--blood
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Biomarkers--analysis
Biomarkers, Tumor--blood
Bone Neoplasms--drug therapy
C-Reactive Protein--metabolism
Cytarabine--therapeutic use
Dexamethasone--therapeutic use
Diphosphonates--therapeutic use
Female
Glycoproteins--metabolism
Humans
Interleukin-6--blood
Isoenzymes--blood
Male
Middle Aged
Multiple Myeloma--drug therapy
Osteocalcin--blood
Osteoclasts--enzymology
Osteogenesis--drug effects
Osteoprotegerin
Pamidronate
Paraproteins--metabolism
Receptors, Cytoplasmic and Nuclear--metabolism
Receptors, Tumor Necrosis Factor
Reference Values
Sensitivity and Specificity
Tartrate-Resistant Acid Phosphatase
Vincristine--therapeutic use
beta 2-Microglobulin--blood